Fate Therapeutics target price cut to $3 from $3.5 by Wells Fargo
FATE•Wells Fargo cut its target price for Fate Therapeutics to $3 from $3.5.
Related News
IMAX Corporation: Wells Fargo cuts target price to $52 from $55
IMAX•
Citigroup cuts HubSpot target price to $230 from $287
HUBS•
TELUS declares quarterly dividend of CAD 0.1875 per share
TU•
Quantinuum Inc: Mizuho cuts target price to $70 from $90
QNT•
Wells Fargo cuts Microchip Technology target price to $70 from $80
MCHP•